Trial Profile
Population pharmacokinetics of tebanicline in subjects with diabetic peripheral neuropathic pain.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2012
Price :
$35
*
At a glance
- Drugs Tebanicline (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 01 Aug 2012 Results published in the Journal of Clinical Pharmacy and Therapeutics.
- 05 Nov 2010 New trial record.